Kinetics and Protein‐Inhibitor Docking Studies of Enantiomers of exo‐2‐Norbornyl‐N‐n‐butylcarbamates as Pseudomonas Lipase Inhibitors to Probe the Enantioselectivity of the Enzyme
Authors:
- 19 January 2012
- journal article
- research article
- Published by Wiley in Journal of the Chinese Chemical Society
- Vol. 59 (1) , 60-65
Abstract
The Pseudomonas species lipase inhibition shows enantioselectivity for R‐enantiomer over S‐enantiomer of exo‐2‐norbornyl‐N‐n‐butylcarbamates. R‐, S‐, and racemic‐exo‐2‐norbornyl‐N‐n‐butylcarbamates are all characterized as pseudo substrate inhibitors of the enzyme. Thus, the mechanism for Pseudomonas species lipase‐catalyzed hydrolysis of the inhibitor is formation of the first enzyme‐inhibitor Michaelis complex via nucleophilic attack of the active site serine to the inhibitor (Ki step) then formation of the butylcarbamyl enzyme intermediate from this complex (k2 step). Comparison of bimolecular rate constants (ki = k2 / Ki) of the inhibitors indicates that R‐enantiomer is 1.8 times more potent than S‐enantiomer. Thus, Pseudomonas species lipase shows enantioselectivity of 1.8 for R‐exo‐2‐norbornyl‐N‐n‐butyl‐carbamate over S‐exo‐2‐norbornyl‐N‐n‐butylcarbamate. Protein‐ligand interaction studies on both enantiomers of exo‐2‐norbornyl‐N‐n‐butylcarbamate as inhibitors of Pseudomonas species lipase using AutoDock suggest that R‐enantiomer binds more tightly into the active site of the enzyme than S‐enantiomer. The norbornyl ring of S‐exo‐2‐norbornyl‐N‐n‐butylcarbamate is repulsive to Ser 82 and His 251 of the catalytic triad as well as to Met 16 of the oxyanion hole. These repulsions may create few unfavorable interactions between S‐exo‐2‐norbornyl‐N‐n‐butylcarbamate and the enzyme and make this inhibitor a less potent one.Keywords
This publication has 32 references indexed in Scilit:
- Stereoselective inhibition of butyrylcholinesterase by enantiomers of exo - and endo -2-norbornyl- N - n -butylcarbamatesJournal of Enzyme Inhibition and Medicinal Chemistry, 2009
- Synthesis of enantiomers ofexo‐2‐norbornyl‐N‐n‐butylcarbamate andendo‐2‐norbornyl‐N‐n‐butylcarbamate for stereoselective inhibition of acetylcholinesteraseChirality, 2009
- QSAR for Inhibition of Pseudomonas Species Lipase by 1‐Acyloxy‐3‐N‐n‐octylcarbamyl‐benzenesQSAR & Combinatorial Science, 2009
- Synthesis of Tricyclic 1,3-Oxazin-4-ones and Kinetic Analysis of Cholesterol Esterase and Acetylcholinesterase InhibitionJournal of Medicinal Chemistry, 2005
- Highly potent and selective 4,4'‐biphenyl‐4‐acylate‐4'‐ N ‐ n ‐butylcarbamate inhibitors of Pseudomonas species lipaseEuropean Journal of Lipid Science and Technology, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Lipase protein engineeringBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- Crystal Structure of Pseudomonas aeruginosa Lipase in the Open ConformationJournal of Biological Chemistry, 2000
- Molecular Recognition by Cholesterol Esterase of Active Site Ligands: Structure−Reactivity Effects for Inhibition by Aryl Carbamates and Subsequent Carbamylenzyme TurnoverBiochemistry, 1996
- Interfacial activation of the lipase–procolipase complex by mixed micelles revealed by X-ray crystallographyNature, 1993